Skip to main content

This is a table comparing concomitant preventive medication use in the treatment of both episodic migraine and chronic migraine during Randomized Controlled Trials (RCTS). Performance is compared for FRAME ERE (Arise) ERE (Strive) GALCA (Evolve 1) GALCA (Evolve 2) and EPTI (Promise 1). Values are expressed as percentages.

Title

Concomitant preventive medication use in phase 3 RCTS

Description

This is a table comparing concomitant preventive medication use in the treatment of both episodic migraine and chronic migraine during Randomized Controlled Trials (RCTS). Performance is compared for FRAME ERE (Arise) ERE (Strive) GALCA (Evolve 1) GALCA (Evolve 2) and EPTI (Promise 1). Values are expressed as percentages.

Type

Table

Category

Outreach and Education

Source 1 of 2

Source

https://www.industrydocuments.ucsf.edu/opioids/docs/#id=hfbp0320

Date

2018

Collection

Teva and Allergan Documents
Source

https://www.industrydocuments.ucsf.edu/opioids/docs/#id=yhhx0345

Date

2018

Collection

Teva and Allergan Documents

We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.

Cite This Image

Information copied to your clipboard:

"Concomitant preventive medication use in phase 3 RCTS." OIDA Image Collection. Available at https://images.oida-resources.jhu.edu/53988687-141e-4fed-...